EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseLeitlinieOpen Access · CC BY 4.0

Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis

Ioana Medrea iD, Paul Cooper, Marissa Langman, Claire H Sandoe iD, Farnaz Amoozegar, Wasif M Hussain iD, Ana C Bradi, Jessica Dawe, Meagan Guay iD, Francois Perreault iD, Stuart Reid, Candice Todd iD und 2 weitere

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025-05 · 52 (3) · 450-472

DOI: 10.1017/cjn.2024.285 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 07.11.2024. Verfasst von Ioana Medrea und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, SUNY Upstate Medical University, Syracuse, NY, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We have updated the migraine prevention guideline of the Canadian Headache Society from 2012, as there are new therapies available, and additionally, we have provided guidelines for the prevention of chronic migraine, which was not addressed in the previous iteration.

Methods

We undertook a systematic review to identify new studies since the last guideline. For studies identified, we performed data extraction and subsequent meta-analyses where possible. We composed a summary of the evidence found and undertook a modified Delphi recommendation process. We provide recommendations for treatments identified and additionally expert guidance on the use of the treatments available in important clinical situations.

Results

We identified 61 studies that were included in this evidence update and identified 16 therapies we focused on. The anti-calcitonin gene-related peptide (CGRP) agents were approved by Health Canada between 2018 and 2024 and provide additional options for episodic and chronic migraine prevention. We also summarize evidence for the use of propranolol, topiramate and onabotulinumtoxinA in addition to anti-CGRP agents as treatments for chronic migraine. We have downgraded topiramate to a weak recommendation for use and gabapentin to a weak recommendation against its use in episodic migraine. We have weakly recommended the use of memantine, levetiracetam, enalapril and melatonin in episodic migraine.

Conclusion

Based on the evidence synthesis, we provide updated recommendations for the prevention of episodic and chronic migraine utilizing treatments available in Canada. We additionally provided expert guidance on their use in clinical situations.

Schlagwörter

Stichwörter der Autor:innen

Migraineguidelineheadachemigraine research

Autor:innen und Institutionen

  • Division of Neurology, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Women's College Hospital, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • London Health Sciences Centre, Division of Neurology, University of Western Ontario, London, ON, Canada.
  • South Health Campus, Alberta Health Services, Division of Neurology, University of Calgary, Calgary, AB, Canada.
  • Kaye Edmonton Clinic, Division of Neurology, University of Alberta, Edmonton, AB, Canada.
  • Ottawa Hospital, Division of Neurology, University of Ottawa, Ottawa, ON, Canada.

ORCID-Profile: Ioana Medrea, Claire H Sandoe, Wasif M Hussain, Meagan Guay, Francois Perreault, Candice Todd

Zitieren

APA

Medrea, I., Cooper, P., Langman, M., Sandoe, C. H., Amoozegar, F., Hussain, W. M., Bradi, A. C., Dawe, J., Guay, M., Perreault, F., Reid, S., Todd, C., Skidmore, B., & Christie, S. N. (2025). Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 52(3), 450-472. https://doi.org/10.1017/cjn.2024.285

Vancouver

Medrea I, Cooper P, Langman M, Sandoe CH, Amoozegar F, Hussain WM, et al. Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2025;52(3):450-472. doi:10.1017/cjn.2024.285

BibTeX
@article{Medrea2025,
  author = {Medrea, Ioana and Cooper, Paul and Langman, Marissa and Sandoe, Claire H and Amoozegar, Farnaz and Hussain, Wasif M and Bradi, Ana C and Dawe, Jessica and Guay, Meagan and Perreault, Francois and Reid, Stuart and Todd, Candice and Skidmore, Becky and Christie, Suzanne N},
  title = {Updated Canadian Headache Society Migraine Prevention Guideline with Systematic Review and Meta-analysis},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2025},
  volume = {52},
  number = {3},
  pages = {450--472},
  doi = {10.1017/cjn.2024.285}
}
Kostenlos starten →